Summary
The paper introduces M3D-LaMed, a generalist large language model designed for comprehensive 3D medical image analysis. The study tackles challenges in 3D medical imaging, such as data scarcity and high computational costs, which previously limited exploration in this field. M3D-LaMed is specialized for eight critical tasks, including image-text retrieval, report generation, visual question answering (VQA), positioning, and segmentation.
Key contributions of the paper include:
M3D-LaMed Model: A multi-modal large language model (MLLM) specifically designed for various 3D medical imaging tasks.
M3D-Data: The largest public 3D multi-modal medical dataset to date, containing 120,000 image-text pairs and 662,000 instruction-response pairs, covering a range of diseases and tasks.
M3D-Bench: The first 3D multi-modal benchmark that evaluates performance across eight 3D medical tasks, with specific metrics for image-text retrieval, VQA, positioning, and segmentation.
The results demonstrate that M3D-LaMed surpasses existing models across these tasks, establishing a robust framework for 3D medical image analysis and promoting further research in medical imaging applications
Strengths
M3D-LaMed represents a highly original application of multi-modal large language models (MLLMs) to the under-explored domain of 3D medical imaging. By moving beyond traditional 2D image analysis, it highlights the added value of 3D data in medical diagnostics, addressing a significant limitation in prior work.
The introduction of a 3D spatial pooling perceiver to efficiently process 3D tokens while maintaining spatial information is a novel approach that creatively adapts existing methods to suit the unique demands of 3D medical data.
M3D-LaMed’s generalist approach and performance across multiple complex tasks make it a significant contribution to the field of medical imaging, as it offers a versatile tool adaptable to various clinical applications.
The publicly available M3D-Data and M3D-Bench will serve as valuable resources for the broader community, facilitating the development and evaluation of future models in 3D medical image analysis.
By addressing spatial and contextual complexity in 3D images, M3D-LaMed enhances diagnostic capabilities, which could translate into better clinical decision-making and improved patient outcomes.
Weaknesses
Lack of Explanation for Resizing Method: The authors mention using Min-Max normalization and resizing 3D CT images to a standard dimension of 32×256×256, but the specific resizing technique used (e.g., interpolation method, aspect ratio considerations) is not clarified. Without this information, it is difficult to assess how the resizing might affect spatial integrity in 3D images, especially for subtle structures critical in medical analysis.
No Comparative Study on Resizing: It would be beneficial if the authors conducted a comparative study to evaluate the effects of different resizing methods on performance, as variations in preprocessing can impact model accuracy on medical data.
Lack of Comparative Analysis with MLP: The paper introduces a 3D Perceiver module to handle token reduction for efficient 3D processing, but it does not compare this approach directly against a simpler alternative, such as a Multi-Layer Perceptron (MLP). A controlled comparison would demonstrate the added value of the 3D Perceiver and validate its effectiveness in preserving spatial information while reducing computation.
No Ablation Study on the 3D Perceiver: Including an ablation study that isolates the impact of the 3D Perceiver module would strengthen the paper by empirically verifying its contribution to the model’s performance.
Limited Comparative Analysis with 2D Models: Although the paper focuses on 3D models, a more detailed comparison with state-of-the-art 2D models on similar tasks (e.g., segmentation or retrieval) would highlight the advantages and limitations of the 3D approach. By doing so, the authors could clarify whether the shift to 3D improves performance in specific areas, such as spatial recognition, and where it might face challenges, such as increased computational costs.
Lack of Discussion on Demographic and Disease Variety: While M3D-Data is substantial in size, the paper does not address whether it includes diverse demographic groups or a wide range of diseases, which are crucial for generalizable models in healthcare. An analysis of the dataset’s coverage across demographic and pathological categories would provide insight into its representativeness and the potential for biases.
Absence of Evaluation for Dataset Representativeness: Ensuring that M3D-Data includes representative samples across age, gender, and disease types would enhance the model’s applicability. Without this, there’s a risk that M3D-LaMed may perform less effectively on underrepresented groups, limiting its utility in real-world clinical applications.
Questions
Could you specify the resizing method used to preprocess 3D CT images to the standard dimension of 32×256×256? For example, was a specific interpolation technique applied, or were aspect ratios adjusted?
Did you compare the 3D Perceiver module directly with a simpler alternative, like an MLP, to assess its contribution to token reduction and spatial information preservation?
Although the focus is on 3D image analysis, did you evaluate M3D-LaMed’s performance against state-of-the-art 2D models on similar tasks to establish a clearer benchmark for the benefits and limitations of 3D approaches?
Could you provide more detail on the demographic diversity (e.g., age, gender, ethnicity) and disease types included in M3D-Data? Was any effort made to ensure the dataset’s representativeness across these dimensions?
M3D-Data primarily consists of CT images. Did you consider evaluating M3D-LaMed’s performance across other 3D imaging modalities, such as MRI or PET, to assess the model’s robustness in handling different data types?
While Dice score is used to measure segmentation performance, did you evaluate M3D-LaMed’s segmentation accuracy with respect to clinically relevant boundaries or subtle anatomical variations?
Could you provide details on the computational requirements for deploying M3D-LaMed in clinical settings? How do its processing times compare to those of 2D models, and what are the implications for clinical feasibility?
Could you clarify the licensing and accessibility of M3D-Data and M3D-Bench? Will these resources be publicly available to the community, and if so, under what conditions?
Given that M3D-LaMed still faces challenges with high-resolution 3D data, do you foresee any future improvements to the model architecture or data processing to better handle long token sequences in 3D?